The Valley Desk

NCT04514653 · Interventional trial

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Overall registry status Active not recruiting

Phase 2

Conditions Neovascular Age-Related Macular Degeneration (nAMD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov